SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 996.8 GBX | +1.14% |
|
+1.61% | -7.58% |
| May. 03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
| May. 02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
Financials (USD)
| Sales 2024 * | 5.82B | Sales 2025 * | 6.12B | Capitalization | 10.91B |
|---|---|---|---|---|---|
| Net income 2024 * | 541M | Net income 2025 * | 694M | EV / Sales 2024 * | 2.31 x |
| Net Debt 2024 * | 2.56B | Net Debt 2025 * | 2.24B | EV / Sales 2025 * | 2.15 x |
| P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
16.1
x | Employees | 18,452 |
| Yield 2024 * |
3.06% | Yield 2025 * |
3.43% | Free-Float | 99.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Smith & Nephew Plc
More recommendations
More press releases
More news
| 1 day | +1.14% | ||
| 1 week | +1.61% | ||
| Current month | +1.82% | ||
| 1 month | +2.13% | ||
| 3 months | -9.13% | ||
| 6 months | +1.55% | ||
| Current year | -7.58% |
1 week
971.60
1 020.00
1 month
946.001 020.00
Current year
946.001 181.50
1 year
887.001 315.00
3 years
887.001 601.50
5 years
887.002 023.00
10 years
881.002 023.00
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 22-03-31 |
John Rogers
DFI | Director of Finance/CFO | 56 | Nov. 30 |
Alison Parkes
CMP | Compliance Officer | - | 99-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 17-09-30 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 23-09-13 |
Rupert Soames
CHM | Chairman | 63 | 23-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.16% | 16 M€ | -4.51% | ||
| 0.52% | 11 M€ | +0.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 996.8 | +1.14% | 2,555,394 |
| 24-05-02 | 985.6 | +0.92% | 5,727,606 |
| 24-05-01 | 976.6 | -0.25% | 3,782,800 |
| 24-04-30 | 979 | -0.51% | 2,266,160 |
| 24-04-29 | 984 | +0.31% | 2,736,964 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.51
USD
Average target price
16.4
USD
Spread / Average Target
+31.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.58% | 10.74B | |
| +2.17% | 8.93B | |
| +22.75% | 7.61B | |
| +33.99% | 5.27B | |
| +8.12% | 3.42B | |
| -8.48% | 2.86B | |
| -5.07% | 2.23B | |
| -4.22% | 2.13B | |
| -20.87% | 1.84B | |
| -4.52% | 1.2B |
- Stock Market
- Equities
- SN. Stock
